Geron Corporation
Guanine analogs as telomerase substrates and telomere length affectors

Last updated:

Abstract:

This invention relates to compounds useful for inhibiting telomere elongation. More specifically, the invention provides nucleotide analogs that are incorporated into telomeres by telomerase thereby inhibiting elongation of telomeres. The compounds are use in treating cancer and other cell proliferative diseases.

Status:
Grant
Type:

Utility

Filling date:

7 Feb 2020

Issue date:

22 Mar 2022